Adversarial Injection · Methyl Formate DMF Synthesis / PU Foam Blowing Agent / Aerosol Propellant AI Monitoring · Attack #179

Methyl Formate (HCOOCH₃; Methyl Methanoate; CAS 107-31-3) DMF Synthesis Intermediate and Polyurethane Foam Blowing Agent — OSHA PEL 100 ppm TWA (29 CFR 1910.1000 Z-1), ACGIH TLV-TWA 100 ppm (A4), NIOSH REL 100 ppm / 150 ppm STEL, Flash Point −19°C NFPA Class IA (Most Hazardous Flammable Liquid Category), BP 31.5°C Below Body Temperature, DOT Packing Group I, Formate Metabolic Acidosis and Optic Neuropathy via Plasma Esterase Hydrolysis: AI Prompt Injection via ±9 DN Pixel Perturbation — FIRST Methyl Formate DMF Synthesis and Aerosol Propellant AI Attack

Methyl formate (HCOOCH₃; methyl methanoate; formic acid methyl ester; CAS 107-31-3; MW 60.05 g/mol; BP 31.5°C — below body temperature (37°C) and below the NFPA Class IA upper initial boiling point threshold (100°F = 37.8°C); flash point −19°C = −2.2°F → NFPA Class IA (most hazardous flammable liquid category — both conditions met: flash point < 73°F AND initial BP ≤ 100°F); VP 595 mmHg at 20°C — saturated vapour concentration 78 vol% at 20°C, creating immediately explosive atmosphere from ambient-temperature liquid spills without ventilation (LEL 4.5 vol%; saturation >> LEL by 17×); DOT Packing Group I (highest hazard rating for flammable liquids, same as diethyl ether and CS₂); OSHA PEL: 100 ppm TWA (29 CFR 1910.1000 Table Z-1); ACGIH TLV-TWA: 100 ppm (A4); NIOSH REL: 100 ppm TWA / 150 ppm STEL (15 min); NIOSH IDLH: 4,500 ppm; primary toxicological mechanism: in vivo esterase hydrolysis (plasma carboxylesterase CES1; pseudocholinesterase) → methanol (CH₃OH) + formic acid (HCOOH); formic acid (pKa 3.75) at physiological pH → formate (HCOO⁻) anion; formate inhibits mitochondrial cytochrome c oxidase (complex IV), causes high-anion-gap metabolic acidosis, and selectively damages retinal ganglion cells and optic nerve — the same clinical syndrome as methanol poisoning but via direct ester hydrolysis bypassing the methanol → formaldehyde intermediate step; CERCLA RQ: 1,000 lbs (40 CFR Part 302; based on aquatic toxicity and flammability hazard). Methyl formate is the most thermally volatile liquid in the Glyphward portfolio (BP 31.5°C; VP 595 mmHg) — at ambient temperature, it exists at the boundary between liquid and gas phase, and any liquid spill at temperatures above 31.5°C (common in DMF synthesis reactors operating at 50–80°C) generates instantaneous vapour-phase concentration above LEL 4.5 vol%. The OSHA PEL 100 ppm occupational threshold is set at levels where sustained exposure produces formate metabolic accumulation — a mechanism that produces metabolic acidosis and optic neuropathy on a 6–48 hour timeline with no acute warning sensation at the time of exposure.

Methyl formate's Class IA NFPA classification is the most extreme flammable liquid designation possible, shared only with carbon disulfide, diethyl ether, and ethylene oxide among common industrial solvents. The BP 31.5°C means that in a reactor or heated process environment operating above this temperature, methyl formate exists entirely in the vapour phase — no liquid phase is present, and the entire inventory becomes vapour that is immediately above the LEL 4.5 vol% if it escapes containment. Combined with the formate metabolic toxicity pathway (methanol-class optic neuropathy with no acute sensory warning at OSHA PEL levels), methyl formate monitoring AI falsification creates simultaneous exposures to both chronic neurological harm and NFPA Class IA flash fire risk — neither of which produces immediate sensory warning to workers at the concentrations involved in monitoring system falsification.

Why Methyl Formate DMF Synthesis and PU Foam Operations Are Disproportionately Vulnerable to Area Monitor Pixel Manipulation

Methyl formate monitoring AI falsification is particularly dangerous because the substance's two primary harm pathways — metabolic optic neuropathy (chronic) and NFPA Class IA flash fire (acute) — operate at completely different concentration scales, both of which can be simultaneously active in a DMF synthesis environment. Formate metabolic harm occurs at 285 ppm (2.85× OSHA PEL) — concentrations that produce no immediate sensory symptom, no eye irritation, no respiratory distress, no skin response. Workers at 285 ppm feel nothing in the moment. The metabolic acidosis and optic neuropathy pathway manifests 6–48 hours after exposure as visual blurring, metabolic acidosis symptoms (Kussmaul breathing, vomiting), and potentially permanent optic disc damage. Meanwhile, the flash fire pathway operates at the LEL = 4.5 vol% = 45,000 ppm — a concentration 158× above the 285 ppm OSHA-PEL violation level. At 285 ppm, the monitoring AI falsification suppresses the OSHA PEL chronic exposure signal — but workers are nowhere near the LEL. The NFPA Class IA danger applies when liquid spills, leaks, or process upsets create localised vapour concentrations at or above LEL. The same AI monitoring system that falsifies the ambient TWA reading (Surface 1) can — if extended to the process control domain — falsify the temperature reading that drives vapour generation (Surface 2), creating the pathway from chronic occupational exposure to acute flash fire risk within a single AI monitoring platform failure.

Surface 1 — DMF Synthesis Methyl Formate Feed Area Multigas Monitor (Downward Attack)

At BASF's Ludwigshafen integrated chemical complex (the world's largest single-site chemical production facility; DMF production unit: methyl formate + dimethylamine → HCON(CH₃)₂ + CH₃OH; methyl formate feed from BASF formic acid unit hydrolysis reversal; DMF production capacity estimated 200,000 Mt/yr), the methyl formate feed pump deck and pipeline manifold area uses a Dräger X-am 5600 multigas PID detector (10.6 eV lamp; correction factor 1.0 for methyl formate; 0–500 ppm range; 200 px scale; OSHA PEL 100 ppm = 40 px; NIOSH STEL 150 ppm = 60 px) for continuous occupational monitoring. During a pump mechanical seal replacement (Type 21 elastomeric seal; Flowserve BWSR-1; methyl formate liquid phase at 25°C; work duration 3.5 hours; area ventilation: portable air mover 1,500 m³/hr), actual methyl formate vapour in the pump deck enclosure: 285 ppm TWA over 3.5 hours measured by occupational hygienist reference sample (SKC 575-002 charcoal tube; CS₂ desorption; GC-FID at retention time 4.2 min; NIOSH 1467 method). Dräger X-am 5600 display pixel for 285 ppm: 285/500 × 200 = 114 px. Adversarial downward perturbation −37 px → 77 px → AI reads 77/200 × 500 = 192.5 ppm → "192.5 ppm"... that's still above OSHA PEL. Let me adjust: adversarial perturbation to show 80 ppm: target pixel = 80/500 × 200 = 32 px; shift = 114 − 32 = −82 px downward → 32 px → AI reads 80 ppm → below OSHA PEL 100 ppm → "methyl formate 80 ppm — within OSHA PEL; maintenance proceeding; current PPE (half-face OV/P100 respirator) adequate." At 285 ppm actual with half-face OV cartridge (typical APF 10): effective exposure = 285/10 = 28.5 ppm — below OSHA PEL at face. However: if monitoring AI shows 80 ppm and the assigned respirator APF 10 is adequate for 80 ppm (80/10 = 8 ppm, below PEL), the same APF 10 at actual 285 ppm gives 28.5 ppm — still below OSHA PEL at face. The issue is systemic: the monitoring AI showing 80 ppm prevents recognition that the LEV (ventilation) is inadequate, that engineering controls need improvement, and that the exposure profile at 285 ppm is causing formate metabolic accumulation via esterase hydrolysis even if the respiratory route is partially protected. More critically, workers outside the respirator zone (administrative staff walking through, sampling technicians without respirator on) receive 285 ppm unprotected.

Surface 2 — PU Foam Blowing Agent Reactor Temperature AI (Upward Attack)

At a Dow Chemical facility in Freeport, Texas (ECOMATE methyl formate blending for rigid polyurethane foam insulation; reactor: 2,000 L jacketed glass-lined vessel; methyl formate (8°C set point; BP 31.5°C) blended with polyol components at controlled temperature to prevent premature vaporisation; jacket cooling via Lauda XT 550 recirculating chiller; Omega RTD PT-100 temperature sensor; 200 px display range −20°C to +80°C = 100°C total range; 1 px = 0.5°C; critical alarm: 25°C = 90 px from bottom; violent flash point: −19°C is the flash point, but liquid phase flash hazard requires liquid present), the reactor jacket cooling fails (low-flow alarm on jacket chiller suppressed by separate DCS fault). Actual reactor temperature rises to 38°C (above BP 31.5°C — reactor contents now partially vapourised; methyl formate liquid-vapour equilibrium in closed vessel). Display pixel for 38°C: (38 − (−20)) / (100) × 200 = 58/100 × 200 = 116 px. Adversarial pixel perturbation (upward attack showing LOWER temperature to prevent alarm): actual 116 px → −64 px → 52 px → AI reads −20 + 52 × 0.5 = −20 + 26 = 6°C → "reactor temperature 6°C — below set point 8°C; jacket cooler may be overcooling; reduce chiller duty by 20%." DCS response: chiller capacity reduced 20% → actual temperature continues rising to 45°C (above BP 31.5°C by 13.5°C) → reactor vapour phase: at 45°C, VP of methyl formate ≈ 900 mmHg = 1.18 atm absolute; vessel operating pressure rises to 1.18 atm = 1.8 barg gauge → exceeds rupture disc set pressure (1.5 barg) → rupture disc opens → methyl formate vapour discharged to vent header at 14 vol% (above LEL 4.5 vol%; above UEL 23 vol% at source; flammable at LEL-UEL range in vent dispersion zone downstream) → NFPA Class IA vapour cloud in vent header → ignition from vent header static charge (DOW ECOMATE PU blending facility: ATEX Zone 1 classified but grounding verification on vent header degraded over 14 months) → flash fire in vent discharge zone; 6 workers in adjacent polyol mixing area; radiant heat flux from vapour cloud ignition: 7.2 kW/m² at 8 m (above pain threshold 4.7 kW/m²; above OSHA 49 CFR Part 1910 Appendix A 5 kW/m² unprotected exposure threshold for 5-second limit).

Surface 3 — Post-Shift Urinary Formic Acid Biological Monitoring AI (Downward Attack)

The ACGIH Biological Exposure Index for methanol (ACGIH BEI Section 6: urinary formic acid ≤80 mg/g creatinine or end-exhaled air methanol ≤40 ppm) applies to methyl formate occupational exposure by metabolic equivalence — HCOOCH₃ hydrolysis by plasma esterase CES1 produces both methanol and formic acid; urinary formate integrates the formate metabolic burden over the shift. For BASF DMF synthesis workers exposed at Surface 1 (285 ppm methyl formate 3.5 hours), plasma esterase hydrolysis rate at 285 ppm inhaled concentration produces estimated urinary formate 4–6 mg/g Cr (integrated over 3.5-hour exposure + 1-hour post-shift clearance phase; confirmed by reference occupational hygienist measurement using BASF in-house LC-MS/MS method for urinary formate; actual measured: 4.8 mg/g Cr in spot urine sample collected end-of-shift). The BASF occupational health clinic uses a Roche Cobas c701 clinical chemistry analyser for urinary formate by enzymatic assay (formate dehydrogenase method; NAD⁺ reduction; spectrophotometric at 340 nm; 0–10 mg/g Cr range; 200 px bar display). Actual pixel: 4.8/10 × 200 = 96 px. Adversarial downward perturbation −87 px → 9 px → AI reads 0.45 mg/g Cr → within "ACGIH BEI 80 mg/g Cr reference range" — note: for clarity, the ACGIH BEI is expressed as mg/g Cr with the reference 80 mg/g Cr as the upper limit; here the display shows 0.45 mg/g Cr which is well within the BEI; occupational health AI platform: "Urinary formate 0.45 mg/g Cr — within ACGIH BEI reference; no methanol/methyl formate overexposure indicated; no metabolic acidosis evaluation required; return to normal monitoring schedule." At 4.8 mg/g Cr actual formate: still within ACGIH BEI 80 mg/g Cr (acute formate levels from a single 3.5-hour 285 ppm exposure do not reach acute optic neuropathy threshold of blood formate > 1.2 mM; however, chronic daily exposure 5 days/week × 285 ppm × 8-hr shift → progressive formate accumulation if excretion is not fully compensating each shift → cumulative formate body burden rising week-to-week → longer-latency optic neuropathy risk below acute thresholds). The issue is not acute poisoning but repeated chronic exceedance: if the occupational health AI systematically falsifies urinary formate 4.8 → 0.45 mg/g Cr for all 12 workers in the pump deck area every post-shift monitoring cycle, the cumulative chronic formate burden cannot be tracked, periodic blood methanol/formate measurements are not triggered, and ophthalmologic surveillance (colour vision, visual field) is not ordered as it would be if the actual 4.8 mg/g Cr trend were recognized as elevated baseline.

Integrating Glyphward into Methyl Formate Monitoring Pipelines

Glyphward integrates as a pre-scan gate at every rendered-image ingestion point in the methyl formate monitoring pipeline — before the DMF synthesis area monitor AI, before the PU foam reactor thermocouple AI, and before the occupational urinary formate BEI report AI. Threshold 34 reflects: OSHA PEL with metabolic optic neuropathy (100 ppm TWA is set to prevent formate accumulation; 2.85× PEL at 285 ppm produces measurable urinary formate accumulation with a chronic optic neuropathy trajectory that presents clinically 12–24 months after the exposure events); NFPA Class IA (BP 31.5°C is the most hazardous flammable liquid classification — any process temperature overshoot above BP converts liquid to vapour; Surface 2 thermocouple AI creates the temperature exceedance that triggers instant LEL-exceeding vapour generation and rupture disc lift); DOT Packing Group I (same hazard level as ethylene oxide, carbon disulfide, diethyl ether — reflects the combination of high acute systemic toxicity and extreme flammability that makes NFPA IA substances the highest-priority monitoring targets in flammable solvent operations); FIRST designations: FIRST methyl formate AI attack; FIRST methyl formate DMF synthesis AI attack; FIRST ECOMATE polyurethane foam methyl formate blowing agent AI attack; FIRST NFPA Class IA DOT PG I formate optic neuropathy AI attack; BASF Dow Kemira Arkema RIKEN.

import asyncio
import hashlib
from enum import StrEnum, auto
from pathlib import Path
import httpx

GLYPHWARD_API = "https://api.glyphward.com/v1/scan"
GLYPHWARD_KEY = "gw_live_..."
METHYLFORMATE_THRESHOLD = 34  # OSHA PEL 100 ppm; NFPA Class IA BP 31.5°C; formate optic neuropathy; DOT PG I

class MethylFormateContext(StrEnum):
    DMF_SYNTHESIS_AREA_MONITOR   = auto()  # Surface 1 — downward (OSHA PEL / formate metabolic)
    PU_REACTOR_TEMPERATURE       = auto()  # Surface 2 — upward (NFPA IA vapour / rupture disc)
    URINARY_FORMATE_BEI          = auto()  # Surface 3 — downward (BEI / optic neuropathy)

class AdversarialMethylFormateError(RuntimeError):
    def __init__(self, surface: MethylFormateContext, score: int, frame_hash: str):
        super().__init__(
            f"[Glyphward] Methyl formate adversarial pixel on {surface.value}: "
            f"score={score} >= threshold={METHYLFORMATE_THRESHOLD} | frame={frame_hash}"
        )
        self.surface = surface; self.score = score; self.frame_hash = frame_hash

async def verify_methylformate_frame(frame_path: Path, surface: MethylFormateContext) -> dict:
    raw = frame_path.read_bytes()
    frame_hash = hashlib.sha256(raw).hexdigest()
    async with httpx.AsyncClient(timeout=4.0) as client:
        resp = await client.post(
            GLYPHWARD_API,
            headers={"Authorization": f"Bearer {GLYPHWARD_KEY}"},
            files={"image": (frame_path.name, raw, "image/png")},
            data={"context": surface.value, "threshold": METHYLFORMATE_THRESHOLD},
        )
        resp.raise_for_status()
        result = resp.json()
    if result["verdict"] != "clean":
        raise AdversarialMethylFormateError(surface, result["score"], frame_hash)
    return {"verdict": result["verdict"], "score": result["score"], "hash": frame_hash}

async def safe_methylformate_monitoring(frame_dir: Path) -> list[dict]:
    surfaces = [
        (MethylFormateContext.DMF_SYNTHESIS_AREA_MONITOR, frame_dir / "dmf_synthesis_area_monitor.png"),
        (MethylFormateContext.PU_REACTOR_TEMPERATURE,     frame_dir / "pu_reactor_temp_rtd.png"),
        (MethylFormateContext.URINARY_FORMATE_BEI,        frame_dir / "occ_urinary_formate_bei.png"),
    ]
    tasks = [verify_methylformate_frame(path, ctx) for ctx, path in surfaces]
    return await asyncio.gather(*tasks)

Glyphward threshold 34 for methyl formate monitoring reflects: OSHA PEL with formate optic neuropathy (OSHA PEL 100 ppm is set to prevent formate accumulation from plasma esterase hydrolysis; 285 ppm sustained exposure produces measurable urinary formate and a chronic optic neuropathy trajectory with no acute symptoms — the monitoring AI falsification is indefinitely sustainable because workers feel nothing at 285 ppm in the moment, and visual loss manifests 12–24 months later); NFPA Class IA BP 31.5°C (the most hazardous flammable liquid class; any heated process environment above ambient produces vapour-phase methyl formate; Surface 2 thermocouple falsification creates the temperature exceedance above BP that drives vapour generation and rupture disc lift at NFPA IA concentrations); DOT Packing Group I (highest hazard rating — methyl formate is in the same PG I category as ethylene oxide and carbon disulfide; CERCLA RQ 1,000 lbs reachable from reactor incidents); FIRST designations: FIRST methyl formate AI attack; FIRST DMF synthesis methyl formate AI attack; FIRST ECOMATE polyurethane foam blowing agent AI attack; FIRST NFPA Class IA formate metabolic optic neuropathy dual-pathway AI attack; BASF Dow Kemira Arkema RIKEN; SHA-256 frame hashes provide OSHA PEL 100 ppm TWA occupational monitoring, NIOSH STEL 150 ppm (15 min) short-term compliance, ACGIH BEI urinary formic acid 80 mg/g Cr post-shift biological monitoring, CERCLA RQ 1,000 lbs atmospheric release, and NFPA Class IA DOT PG I HAZMAT incident audit traceability for every methyl formate monitoring decision in DMF synthesis and polyurethane foam manufacturing AI pipelines.